Pfizer (PFE) Q3 2017 Results - Earnings Call Transcript

11/1/17

Pfizer Inc. (NYSE:PFE)

Q3 2017 Earnings Call

October 31, 2017 10:00 am ET

Executives

Charles E. Triano - Pfizer Inc.

Ian C. Read - Pfizer Inc.

Frank A. D'Amelio - Pfizer Inc.

Albert Bourla - Pfizer Inc.

Mikael Dolsten - Pfizer Inc.

John D. Young - Pfizer Inc.

Douglas M. Lankler - Pfizer Inc.

Analysts

Umer Raffat - Evercore ISI

Christopher Schott - JPMorgan Securities LLC

Andrew S. Baum - Citigroup Global Markets Ltd.

Gregg Gilbert - Deutsche Bank Securities, Inc.

David Maris - Wells Fargo Securities LLC

Jami Rubin - Goldman Sachs & Co. LLC

Seamus Fernandez - Leerink Partners LLC

Vamil K. Divan - Credit Suisse Securities (NYSE:USA) LLC

David R. Risinger - Morgan Stanley & Co. LLC

Tim Anderson - Sanford C. Bernstein & Co. LLC

John T. Boris - SunTrust Robinson Humphrey, Inc.

Richard J. Purkiss - Piper Jaffray Ltd.

Steve Scala - Cowen and Co. LLC

Alex Arfaei - BMO Capital Markets (United States)

Marc Goodman - UBS Securities LLC

Olivia Brayer - Guggenheim Securities LLC

Jeffrey Holford - Jefferies LLC

Geoffrey Meacham - Barclays Capital, Inc.

Operator

Good day, everyone, and welcome to Pfizer's third quarter 2017 earnings conference call. Today's call is being recorded.

At this time, I would like to turn the call over to Mr. Chuck Triano, Senior Vice President of Investor Relations. Please go ahead, sir.

'READ FULL ARTICLE HERE